Parkinson Risk in Idiopathic REM Sleep Behavior Disorder: Preparing for Neuroprotective Trials

Overview

Journal Neurology

Specialty Neurology

Date 2015 Feb 15

PMID 25681454

Citations 166

Authors

Ronald B Postuma

Jean-Francois Gagnon

Josie-Anne Bertrand

Daphne Genier Marchand

Jacques Y Montplaisir

Affiliations

Soon will be listed here.

Abstract

Objective: To precisely delineate clinical risk factors for conversion from idiopathic REM sleep behavior disorder (RBD) to Parkinson disease, dementia with Lewy bodies, and multiple system atrophy, in order to enable practical planning and stratification of neuroprotective trials against neurodegenerative synucleinopathy.

Methods: In a 10-year prospective cohort, we tested prodromal Parkinson disease markers in 89 patients with idiopathic RBD. With Kaplan-Meier analysis, we calculated risk of neurodegenerative synucleinopathy, and using Cox proportional hazards, tested the ability of prodromal markers to identify patients at higher disease risk. By combining predictive markers, we then designed stratification strategies to optimally select patients for definitive neuroprotective trials.

Results: The risk of defined neurodegenerative synucleinopathy was high: 30% developed disease at 3 years, rising to 66% at 7.5 years. Advanced age (hazard ratio [HR] = 1.07), olfactory loss (HR = 2.8), abnormal color vision (HR = 3.1), subtle motor dysfunction (HR = 3.9), and nonuse of antidepressants (HR = 3.5) identified higher risk of disease conversion. However, mild cognitive impairment (HR = 1.8), depression (HR = 0.63), Parkinson personality, treatment with clonazepam (HR = 1.3) or melatonin (HR = 0.55), autonomic markers, and sex (HR = 1.37) did not clearly predict clinical neurodegeneration. Stratification with prodromal markers increased risk of neurodegenerative disease conversion by 200%, and combining markers allowed sample size reduction in neuroprotective trials by >40%. With a moderately effective agent (HR = 0.5), trials with fewer than 80 subjects per group can demonstrate definitive reductions in neurodegenerative disease.

Conclusions: Using stratification with simply assessed markers, it is now not only possible, but practical to include patients with RBD in neuroprotective trials against Parkinson disease, multiple system atrophy, and dementia with Lewy bodies.

Citing Articles

Factors associated with phenoconversion of idiopathic rapid eye movement sleep behavior disorder: a prospective study.

Yuan Y, Li Y, Zhang H, Zang Y, Liu X, Hou Y NPJ Parkinsons Dis. 2025; 11(1):10.

PMID: 39762239 PMC: 11704329. DOI: 10.1038/s41531-024-00856-2.

The causal relationship between type 2 diabetes mellitus and isolated REM sleep behavior disorder: results from multivariable and network Mendelian randomization analysis.

Zhang R, Li J, Liu Y, Zhang Z, Zhao J, Li F Front Endocrinol (Lausanne). 2024; 15:1408053.

PMID: 39655344 PMC: 11625559. DOI: 10.3389/fendo.2024.1408053.

CD4+ T-cell transcription factors predict phenoconversion in idiopathic rapid eye movement sleep behavior disorder.

Pinoli M, Terzaghi M, Marino F, Comi C, Versino M, Cosentino M Future Sci OA. 2024; 10(1):2418821.

PMID: 39539158 PMC: 11572078. DOI: 10.1080/20565623.2024.2418821.

The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?.

Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, Chodari L, Nezhadshahmohammad F AIMS Neurosci. 2024; 11(3):374-397.

PMID: 39431275 PMC: 11486621. DOI: 10.3934/Neuroscience.2024023.

Clinical characteristics and phenoconversion in isolated REM sleep behavior disorder: a prospective single-center study in Korea, compared with Montreal cohort.

Byun J, Sunwoo J, Shin Y, Shin J, Kim T, Jun J J Clin Sleep Med. 2024; 21(1):81-88.

PMID: 39177811 PMC: 11701292. DOI: 10.5664/jcsm.11318.

References

Postuma R, Lang A, Massicotte-Marquez J, Montplaisir J . Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006; 66(6):845-51. DOI: 10.1212/01.wnl.0000203648.80727.5b. View

Schenck C, Montplaisir J, Frauscher B, Hogl B, Gagnon J, Postuma R . Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013; 14(8):795-806. PMC: 8783206. DOI: 10.1016/j.sleep.2013.02.016. View

Postuma R, Gagnon J, Vendette M, Montplaisir J . Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain. 2009; 132(Pt 12):3298-307. DOI: 10.1093/brain/awp244. View

Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, Seppi K . White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011; 69(2):400-7. DOI: 10.1002/ana.22245. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Postuma R, Gagnon J, Rompre S, Montplaisir J . Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010; 74(3):239-44. PMC: 2872606. DOI: 10.1212/WNL.0b013e3181ca0166. View

Schenck C, Boeve B, Mahowald M . Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013; 14(8):744-8. DOI: 10.1016/j.sleep.2012.10.009. View

Postuma R, Gagnon J, Vendette M, Fantini M, Massicotte-Marquez J, Montplaisir J . Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2008; 72(15):1296-300. PMC: 2828948. DOI: 10.1212/01.wnl.0000340980.19702.6e. View

Dang-Vu T, Gagnon J, Vendette M, Soucy J, Postuma R, Montplaisir J . Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder. Neurology. 2012; 79(24):2302-6. PMC: 3578380. DOI: 10.1212/WNL.0b013e318278b658. View

10.

Wing Y, Li S, Mok V, Lam S, Tsoh J, Chan A . Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2012; 83(4):470-2. DOI: 10.1136/jnnp-2011-301232. View

11.

Postuma R, Lang A, Gagnon J, Pelletier A, Montplaisir J . How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain. 2012; 135(Pt 6):1860-70. DOI: 10.1093/brain/aws093. View

12.

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

13.

Boeve B, Silber M, Ferman T, Lin S, Benarroch E, Schmeichel A . Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013; 14(8):754-62. PMC: 3745815. DOI: 10.1016/j.sleep.2012.10.015. View

14.

Postuma R, Gagnon J, Montplaisir J . REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis. 2011; 46(3):553-8. DOI: 10.1016/j.nbd.2011.10.003. View

15.

Petersen R . Clinical practice. Mild cognitive impairment. N Engl J Med. 2011; 364(23):2227-34. DOI: 10.1056/NEJMcp0910237. View

16.

Ishihara L, Brayne C . What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord. 2006; 21(8):1066-72. DOI: 10.1002/mds.20980. View

17.

Postuma R, Lanfranchi P, Blais H, Gagnon J, Montplaisir J . Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord. 2010; 25(14):2304-10. DOI: 10.1002/mds.23347. View

18.

Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K . Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006; 67(12):2236-8. DOI: 10.1212/01.wnl.0000249313.25627.2e. View

19.

Dubois B, Burn D, Goetz C, Aarsland D, Brown R, Broe G . Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007; 22(16):2314-24. DOI: 10.1002/mds.21844. View

20.

Postuma R, Gagnon J, Vendette M, Charland K, Montplaisir J . Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008; 23(12):1665-72. DOI: 10.1002/mds.22099. View